Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions
AACE Endocrinology and Diabetes · 2026-11
DOI: 10.1016/j.aed.2026.10.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-11. Verfasst von Aimen Iqbal und 2 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Iqbal, A., Radaideh, T., & Syed, M. (2026). Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.10.017
Vancouver
Iqbal A, Radaideh T, Syed M. Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.10.017
BibTeX
@article{Iqbal2026,
author = {Iqbal, Aimen and Radaideh, Tala and Syed, Muneebuddin},
title = {Tirzepatide and Male Obesity-Related Secondary Hypogonadism: Mechanistic Rationale, Emerging Evidence, and Future Directions},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.10.017}
}
EUVIMED